Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio

Two-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association be...

Full description

Saved in:
Bibliographic Details
Main Authors: Cierra S. Hong, Sean P. Ryan, Jonathan A. Gabor, Michael A. Bergen, Ran Schwarzkopf, Thorsten M. Seyler
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Advances in Orthopedics
Online Access:http://dx.doi.org/10.1155/2019/6521941
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554668638601216
author Cierra S. Hong
Sean P. Ryan
Jonathan A. Gabor
Michael A. Bergen
Ran Schwarzkopf
Thorsten M. Seyler
author_facet Cierra S. Hong
Sean P. Ryan
Jonathan A. Gabor
Michael A. Bergen
Ran Schwarzkopf
Thorsten M. Seyler
author_sort Cierra S. Hong
collection DOAJ
description Two-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association between CAR and reimplantation success during two-stage revision for PJI defined by the Musculoskeletal Infection Society following a primary total hip (THA) or knee (TKA) arthroplasty. From January, 2005 to December, 2015, two institutional databases were queried and patient demographics, antibiotic duration, C-reactive protein, and albumin were collected prior to reimplantation. Two-stage revisions were considered successful if patients were off of antibiotics and did not require a repeat surgery. CAR was available for 79 patients (34 hips and 46 knees) with 61 successful two-stage revisions and 18 failures. The average CAR for patients with successful reimplantation was 1.2 (0.2, 3.0) compared to 1.0 (0.4, 3.2) for treatment failure. However, this was not statistically significant (p=0.766). Therefore, CAR is not applicable in predicting the prognosis of two-stage revisions for PJI in total arthroplasty but other preoperative inflammatory-based prognostic scores should be explored.
format Article
id doaj-art-dbc529f3b8434ce68a51869105d5596f
institution Kabale University
issn 2090-3464
2090-3472
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Advances in Orthopedics
spelling doaj-art-dbc529f3b8434ce68a51869105d5596f2025-02-03T05:50:54ZengWileyAdvances in Orthopedics2090-34642090-34722019-01-01201910.1155/2019/65219416521941Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin RatioCierra S. Hong0Sean P. Ryan1Jonathan A. Gabor2Michael A. Bergen3Ran Schwarzkopf4Thorsten M. Seyler5Duke University Medical Center, Durham, NC, USADuke University Medical Center, Durham, NC, USANYU Langone Health, New York City, NY, USADuke University Medical Center, Durham, NC, USANYU Langone Health, New York City, NY, USADuke University Medical Center, Durham, NC, USATwo-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association between CAR and reimplantation success during two-stage revision for PJI defined by the Musculoskeletal Infection Society following a primary total hip (THA) or knee (TKA) arthroplasty. From January, 2005 to December, 2015, two institutional databases were queried and patient demographics, antibiotic duration, C-reactive protein, and albumin were collected prior to reimplantation. Two-stage revisions were considered successful if patients were off of antibiotics and did not require a repeat surgery. CAR was available for 79 patients (34 hips and 46 knees) with 61 successful two-stage revisions and 18 failures. The average CAR for patients with successful reimplantation was 1.2 (0.2, 3.0) compared to 1.0 (0.4, 3.2) for treatment failure. However, this was not statistically significant (p=0.766). Therefore, CAR is not applicable in predicting the prognosis of two-stage revisions for PJI in total arthroplasty but other preoperative inflammatory-based prognostic scores should be explored.http://dx.doi.org/10.1155/2019/6521941
spellingShingle Cierra S. Hong
Sean P. Ryan
Jonathan A. Gabor
Michael A. Bergen
Ran Schwarzkopf
Thorsten M. Seyler
Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
Advances in Orthopedics
title Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
title_full Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
title_fullStr Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
title_full_unstemmed Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
title_short Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
title_sort predicting success of two stage exchange for prosthetic joint infection using c reactive protein albumin ratio
url http://dx.doi.org/10.1155/2019/6521941
work_keys_str_mv AT cierrashong predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio
AT seanpryan predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio
AT jonathanagabor predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio
AT michaelabergen predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio
AT ranschwarzkopf predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio
AT thorstenmseyler predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio